A breakthrough for biomedical research promises new insight into immunotherapy development and disease modeling.
Satsuma’s NDA filing after CMC woes; Hovione’s Irish and US expansion
Welcome to Endpoints News’ manufacturing briefs, where we bring you essential news on new builds, collaborations, recalls and more. The FDA has Sign up to